G

Genpharmasec Ltd
BSE:531592

Watchlist Manager
Genpharmasec Ltd
BSE:531592
Watchlist
Price: 3.07 INR -2.23% Market Closed
Market Cap: 1.6B INR
Have any thoughts about
Genpharmasec Ltd?
Write Note

Genpharmasec Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genpharmasec Ltd
Cost of Revenue Peer Comparison

Comparables:
S
512463
MSTCLTD
ADANIENT
REFEX
INDIAMART

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
G
Genpharmasec Ltd
BSE:531592
Cost of Revenue
-â‚ą239.6m
CAGR 3-Years
4%
CAGR 5-Years
-109%
CAGR 10-Years
N/A
S
Shree Global Tradefin Ltd
BSE:512463
Cost of Revenue
-â‚ą7.2B
CAGR 3-Years
-863%
CAGR 5-Years
-124%
CAGR 10-Years
N/A
MSTC Ltd
NSE:MSTCLTD
Cost of Revenue
-â‚ą651.9m
CAGR 3-Years
42%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Adani Enterprises Ltd
NSE:ADANIENT
Cost of Revenue
-â‚ą489.1B
CAGR 3-Years
-11%
CAGR 5-Years
-6%
CAGR 10-Years
-2%
Refex Industries Ltd
NSE:REFEX
Cost of Revenue
-â‚ą11.9B
CAGR 3-Years
-31%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Indiamart Intermesh Ltd
NSE:INDIAMART
Cost of Revenue
-â‚ą16.9m
CAGR 3-Years
-60%
CAGR 5-Years
6%
CAGR 10-Years
N/A

See Also

What is Genpharmasec Ltd's Cost of Revenue?
Cost of Revenue
-239.6m INR

Based on the financial report for Jun 30, 2024, Genpharmasec Ltd's Cost of Revenue amounts to -239.6m INR.

What is Genpharmasec Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-109%

Over the last year, the Cost of Revenue growth was -13%. The average annual Cost of Revenue growth rates for Genpharmasec Ltd have been 4% over the past three years , -109% over the past five years .

Back to Top